Back
Fomento Economico Mexicano SAB de CV Vs. Denali Therapeutics Industry Stock Comparison
Buy
53
FMX
Fomento Economico Mexicano SAB de CV
Last Price:
96.88
Seasonality Move:
5.76%
Buy
68
DNLI
Denali Therapeutics
Last Price:
31.31
Seasonality Move:
6.34%
Buy
53
Fomento Economico Mexicano SAB de CV (FMX)
is a Buy
Is Fomento Economico Mexicano SAB de CV a Buy, Sell or Hold?
- The current Fomento Economico Mexicano SAB de CV [FMX] share price is $96.87. The Score for FMX is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
- FMX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
68
Denali Therapeutics (DNLI)
is a Buy
Is Denali Therapeutics a Buy, Sell or Hold?
- The current Denali Therapeutics [DNLI] share price is $31.35. The Score for DNLI is 68, which is 36% above its historic median score of 50, and infers lower risk than normal.
- DNLI is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
FMX Stock Price Chart
What is Fomento Economico Mexicano SAB de CV's stock price today?
-
The Fomento Economico Mexicano SAB de CV share price today is $96.87
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and FMX is experiencing buying pressure, which is a positive indicator for future bullish movement.
DNLI Stock Price Chart
What is Denali Therapeutics's stock price today?
-
The Denali Therapeutics share price today is $31.35
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and DNLI is experiencing buying pressure, which is a positive indicator for future bullish movement.
FMX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.91 | Sell |
| Relative Strength Index (14 RSI): | 44.43 | Sell |
| Chaikin Money Flow: | 280431 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (96.71 - 98.67) | Sell |
| Bollinger Bands (100): | (98.67 - 111.27) | Sell |
DNLI Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.53 | Buy |
| Relative Strength Index (14 RSI): | 68.76 | Buy |
| Chaikin Money Flow: | 648733 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (26.03 - 28.61) | Buy |
| Bollinger Bands (100): | (22.45 - 28.23) | Buy |
FMX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 96.76 | Buy |
| 20-day SMA: | 97.39 | Sell |
| 50-day SMA: | 99.51 | Sell |
| 200-day SMA: | 114.45 | Sell |
| 8-day EMA: | 96.91 | Sell |
| 20-day EMA: | 97.52 | Sell |
| 50-day EMA: | 100.1 | Sell |
| 200-day EMA: | 108.91 | Sell |
DNLI Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 28.16 | Buy |
| 20-day SMA: | 27.44 | Buy |
| 50-day SMA: | 27.75 | Buy |
| 200-day SMA: | 22.07 | Buy |
| 8-day EMA: | 28.79 | Buy |
| 20-day EMA: | 27.93 | Buy |
| 50-day EMA: | 27.13 | Buy |
| 200-day EMA: | 23.94 | Buy |
Fomento Economico Mexicano SAB de CV Earnings Growth & FMX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.19 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.72 per share, and an increase next year of $0.02 per share.
Denali Therapeutics Earnings Growth & DNLI Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.40 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.87 per share, and an increase next year of $0.05 per share.
Fomento Economico Mexicano SAB de CV Technical Analysis
| Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 28 | 29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Denali Therapeutics Technical Analysis
| Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 28 | 29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||